Search Results - R. Dinavahi
- Showing 1 - 4 results of 4
-
1
-
2
-
3
C023 | UPDATED CLINICAL RESULTS: A MULTICENTER, OPEN-LABEL, PHASE 3 STUDY OF TABELECLEUCEL FOR SOLID ORGAN OR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS WITH EBV-DRIVEN PO... by F.G. Rossi Dardanoni, A. Ghobadi, R. Baiocchi, A.M. Beitinjaneh, S. Chaganti, S. Choquet, D. Dierickx, R. Dinavahi, X. Duan, L. Gamelin, K.M. Mahadeo, A. Mehta, S. Nikiforow, R. Reshef, S. Roye, J.C. Vedovato
Published in Haematologica (2025-09-01)Get full text
Article -
4
S256: TABELECLEUCEL FOR EBV-DRIVEN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL OR SOLID ORGAN TRANSPLANT AFTER FAILURE OF RITUXIMAB ± CHEMOT... by S. Prockop, MD, A. Beitinjaneh, MD, S. Choquet, MD, S. Dahiya, MD, R. Dinavahi, MD, R. Farah, MD, L. Gamelin, MD, PhD, A. Ghobadi, MD, A. Mehta, P. Nayak, MD, R. Reshef, MD, G. Satyanarayana, MD, P. Stiff, MD, W. Ye, PhD, K. M. Mahadeo, MD, MPH
Published in HemaSphere (2022-06-01)Get full text
Article
